Skip to main content
. Author manuscript; available in PMC: 2020 Mar 15.
Published in final edited form as: Cancer Res. 2018 Dec 12;79(6):1151–1164. doi: 10.1158/0008-5472.CAN-18-0779

Figure 4.

Figure 4.

(A) Growth curves of CHLA-136 and LAN-5 cells treated with Dotap-miR-186 or Dotap-Scr and followed for up to 72 hours. (B) Wound-healing assays of CHLA-136 and LAN-5 cells treated with Dotap-miR-186 or Dotap-Scr. The gap size after 6 days is expressed as a percentage of the gap size at time zero. (C) Boyden chamber migration assay of LAN-5 cells treated with Dotap-miR-186 or Dotap-Scr and exposed to SDF1a for 4 hours; the absolute number of migrated cells is reported. (D) Expression of MMP-12 and Vimentin by SYBR-green qRT-PCR in CHLA-136 or LAN-5 cells treated with Dotap-miR-186 or Dotap-Scr. * P<0.05, **P<0.01, ***P<0.001. Student’s t-test, two-tailed.